# Pentoxifylline in Diabetic Kidney Disease

> **NCT03625648** · PHASE4 · ACTIVE_NOT_RECRUITING · sponsor: **VA Office of Research and Development** · enrollment: 2376 (actual)

## Conditions studied

- Diabetic Kidney Disease

## Interventions

- **DRUG:** Pentoxifylline
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT03625648
- **Lead sponsor:** VA Office of Research and Development
- **Sponsor class:** FED
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2019-11-18
- **Primary completion:** 2028-01-03
- **Final completion:** 2030-07-08
- **Target enrollment:** 2376 (ACTUAL)
- **Last updated:** 2026-04-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03625648

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03625648, "Pentoxifylline in Diabetic Kidney Disease". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT03625648. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*